Biotechnology Synthetic Biology Law In Ukraine.
1. Introduction
Synthetic biology is an advanced branch of biotechnology that combines genetic engineering, molecular biology, computational science and biological engineering to design, modify or construct new biological systems.
It includes technologies such as:
Synthetic DNA and genome construction.
CRISPR-Cas gene editing.
Artificial microorganisms and engineered bacteria.
Synthetic genomes and minimal cells.
Gene drives and genetically modified organisms (GMOs).
Engineered enzymes and biological manufacturing.
Synthetic biology applications in medicine, agriculture and pharmaceuticals.
Artificial biological systems used in environmental protection.
Ukraine does not currently have a single comprehensive statute exclusively entitled the Synthetic Biology Act. Instead, synthetic biology is regulated through legislation on genetic engineering, GMOs, biosafety, environmental protection, medicines, food safety, public health, intellectual property and international obligations.
The most important legislation is the Law of Ukraine No. 3339-IX of 23 August 2023, concerning state regulation of genetic engineering activities and state control over the placing of genetically modified organisms and products on the market.
The legislation establishes a framework for controlling the creation, testing, handling and commercial use of genetically modified organisms.
ipLex Законодавство України+1
2. Constitutional and Legal Foundations
The Ukrainian Constitution provides the general legal foundation for synthetic biology regulation.
Important constitutional provisions include:
Article 3 – Human dignity and safety
Human life, health and safety are recognized as important constitutional values. Biotechnology research must therefore respect human dignity and fundamental rights.
Article 16 – Environmental protection
The Constitution establishes the state's responsibility to ensure ecological safety and maintain ecological balance.
Article 27 – Right to life
Biotechnology activities that may threaten human life must be subject to appropriate safeguards.
Article 28 – Human dignity
Scientific and medical experimentation must respect human dignity and the prohibition of degrading treatment.
Article 50 – Environmental rights
Everyone has the right to an environment that is safe for life and health and to access environmental information.
These constitutional principles influence decisions involving experimental organisms, synthetic microorganisms, gene editing and environmental release.
3. Principal Legislation Governing Synthetic Biology
A. Law No. 3339-IX of 2023
This is the central modern legislative framework for genetic engineering and GMO regulation.
Its principal objectives include:
Protecting human health.
Protecting biodiversity and the environment.
Ensuring genetic and biological safety.
Regulating genetic-engineering activities.
Establishing requirements for GMO registration.
Controlling the placing of GMOs and products on the market.
Establishing liability for regulatory violations.
The law distinguishes between closed-system activities and open-system activities.
Closed-system activities
These include laboratory and industrial activities in which genetically modified organisms are handled under containment conditions.
Examples include:
Engineered bacteria in research laboratories.
Genetically modified yeast used in pharmaceutical production.
Synthetic microorganisms used for enzyme production.
Genetically engineered cells used in controlled experiments.
Open-system activities
These involve potential contact between GMOs and humans, other living organisms or the natural environment.
Examples include:
Experimental cultivation of genetically modified plants.
Environmental release trials.
Field testing of engineered microorganisms.
Commercial use of GMOs outside containment facilities.
The distinction is important because environmental exposure generally requires more extensive risk assessment and regulatory oversight.
ipLex Законодавство України
B. Law No. 1103-V of 31 May 2007
The Law on the State System of Biosafety in the Creation, Testing, Transportation and Use of Genetically Modified Organisms established an earlier biosafety framework.
It addresses:
Genetic engineering research.
Laboratory containment.
GMO testing.
Transportation and storage.
Import and export.
Environmental release.
Registration and monitoring.
Public access to information.
It also establishes that unregistered GMOs cannot ordinarily be industrially produced or placed on the market, subject to applicable research and testing exceptions.
This law remains part of the historical and legislative framework, but must be read together with the newer 2023 legislation and its transitional and amendment provisions.
president.gov.ua+1
C. Environmental Impact Assessment Law, 2017
The Law of Ukraine on Environmental Impact Assessment is relevant where synthetic biology projects may affect the environment.
It is particularly important for:
Outdoor GMO experiments.
Industrial biological production facilities.
Environmental release of engineered organisms.
Projects involving potential biodiversity effects.
Biological waste disposal.
An environmental assessment helps determine whether a project may cause significant environmental harm and what protective conditions are necessary.
D. Public Health Legislation
The Law of Ukraine on the Public Health System provides additional safeguards concerning biological risks and threats to human health.
It is relevant to synthetic biology research involving pathogenic organisms, biological agents and potentially hazardous laboratory activities.
E. Food and Feed Safety Legislation
The following legislation is also relevant:
Law on Basic Principles and Requirements for Food Safety and Quality.
Law on Consumer Information about Food Products.
Law on Feed Safety and Hygiene.
Law on State Control of Food and Feed Legislation.
These laws become important when synthetic biology is used to manufacture food ingredients, enzymes, animal feed or genetically modified agricultural products.
4. Regulation of CRISPR and Genome-Editing Technologies
CRISPR-Cas9 and other genome-editing technologies are particularly important to synthetic biology because they allow scientists to modify genetic material with considerable precision.
In Ukraine, the regulatory question is whether the resulting organism falls within the statutory definition of a GMO and whether the particular technique is classified as genetic engineering under the applicable legislation.
Important legal issues include:
Whether CRISPR-modified organisms require regulatory approval.
Whether organisms containing no foreign DNA are treated differently.
Whether gene-edited agricultural organisms require registration.
Whether laboratory research can be conducted under containment conditions.
Whether environmental release requires prior authorization.
Whether the resulting organism can be commercially marketed.
Whether the developer must demonstrate environmental and biological safety.
Legal significance: The absence of foreign DNA does not automatically establish that a gene-edited organism is outside GMO regulation. The applicable statutory definitions, the technique used and the implementing rules must be examined.
Ukraine's 2023 legislation provides for the classification of genetic-engineering methods and includes transitional provisions concerning methods that produce GMOs and methods that do not. This makes the eventual classification of newer genome-editing techniques particularly important.
ipLex Законодавство України+1
5. Laboratory Biosafety and Containment Requirements
Synthetic biology laboratories may work with engineered microorganisms, modified viruses, artificial genetic sequences and biological production systems.
The Ukrainian legal framework distinguishes between controlled laboratory activities and activities involving potential environmental exposure.
The Ministry of Health's Order No. 1018 of 26 June 2025 approved sanitary rules for handling GMOs during genetic-engineering activities in a closed system.
These requirements are relevant to:
Laboratory infrastructure.
Biological containment.
Safe handling of engineered microorganisms.
Prevention of accidental release.
Storage and transportation.
Biological waste management.
Personnel and institutional safety procedures.
The applicable risk controls depend on the nature of the organism, its biological characteristics and the particular activity.
zakon.rada.gov.ua
6. Registration and Commercialization of Synthetic Biological Products
Synthetic biology has significant commercial applications, including:
Engineered enzymes.
Synthetic vaccines.
Recombinant proteins.
Biopharmaceuticals.
Genetically engineered agricultural products.
Industrial microorganisms.
Synthetic biological materials.
The legal treatment depends on the final product and its intended use.
For example:
| Product | Relevant legal framework |
|---|---|
| Genetically engineered agricultural organism | GMO legislation |
| Engineered food ingredient | GMO and food-safety legislation |
| Recombinant therapeutic protein | Pharmaceutical and medicinal-product regulation |
| Synthetic vaccine | Medicinal-product and public-health legislation |
| Engineered industrial microorganism | Biosafety and applicable environmental legislation |
| Genetically modified seed | GMO and seed legislation |
Cabinet of Ministers Resolution No. 584 of 21 May 2025 establishes procedures concerning state registration of GMOs.
Resolution No. 451 of 15 April 2025 regulates the State Register of Genetically Modified Organisms.
These measures are important for determining whether a genetically engineered organism can lawfully enter the relevant regulated market.
zakon.rada.gov.ua
7. Environmental Protection and Synthetic Biology
Environmental protection is one of the most significant legal dimensions of synthetic biology.
Engineered organisms may interact with natural ecosystems, reproduce, transfer genetic material or affect other species.
Potential risks include:
Uncontrolled biological propagation.
Genetic contamination of conventional crops.
Disruption of biodiversity.
Horizontal gene transfer.
Changes to soil microorganisms.
Unexpected ecological consequences.
Long-term environmental persistence.
The Environmental Impact Assessment framework is relevant to projects that fall within its statutory scope.
An especially important provision is Article 51 of the Ukrainian Law on Fauna, as amended by the 2023 GMO legislation. It provides that the creation and use of new microorganism strains, biologically active substances and other biotechnology products, apart from GMOs and GMO products, must be conducted according to law and with a positive environmental impact assessment conclusion.
This provision is important because it shows that certain biotechnology activities may require environmental assessment even when the resulting product is not legally classified as a GMO.
ipLex Законодавство України+1
8. International Legal Framework
Ukraine's synthetic biology framework must also be considered in light of international environmental and biosafety obligations.
A. Cartagena Protocol on Biosafety
The Cartagena Protocol to the Convention on Biological Diversity concerns the safe handling, transport and use of living modified organisms resulting from modern biotechnology.
Its important principles include:
Advance informed agreement for specified transboundary movements.
Risk assessment.
Risk management.
Information exchange.
Biosafety information systems.
Precautionary decision-making.
It is especially relevant when Ukraine imports or exports living modified organisms.
B. Convention on Biological Diversity
The Convention on Biological Diversity establishes international commitments concerning biodiversity conservation, sustainable use and equitable benefit-sharing.
These principles are relevant to synthetic biology applications involving genetic resources.
C. Nagoya Protocol
The Nagoya Protocol concerns access to genetic resources and the fair and equitable sharing of benefits arising from their utilization.
It becomes relevant where synthetic biology research uses biological material or genetic resources obtained from another country.
D. European Union regulatory alignment
Ukraine's European integration makes EU biotechnology and GMO regulatory standards especially relevant.
Important EU instruments include:
Directive 2001/18/EC on deliberate release of GMOs.
Regulation (EC) No. 1829/2003 on genetically modified food and feed.
Regulation (EC) No. 1830/2003 on traceability and labelling of GMOs.
Directive 2009/41/EC on contained use of genetically modified microorganisms.
These instruments are useful for understanding the European regulatory model, although EU legislation should not automatically be treated as directly applicable Ukrainian domestic law.
9. Important Case Laws and Judicial Principles
A significant distinction must be made between Ukrainian judicial decisions and foreign judgments relevant to Ukraine's synthetic biology framework.
There is no clearly established, reported Ukrainian Supreme Court precedent specifically deciding the legality of synthetic genomes, CRISPR-designed organisms or commercial synthetic microorganisms. Consequently, the following EU judgments are comparative authorities, not binding Ukrainian precedents.
Case 1. Confédération paysanne v Premier ministre (2018)
Court of Justice of the European Union · Case C-528/16 · Judgment of 25 July 2018
Background:
The case concerned genetically modified organisms produced through mutagenesis techniques.
The applicants challenged the exclusion of certain mutagenesis-derived organisms from EU GMO regulation.
Legal question:
Whether organisms obtained through newer genetic modification techniques should be treated as GMOs under Directive 2001/18/EC.
Judgment:
The CJEU held that organisms obtained through mutagenesis are GMOs within the meaning of the directive. Only techniques that had conventionally been used in several applications and had a long safety record qualified for the relevant exemption.
Importance for Ukraine:
This judgment provides an important comparative principle for regulating CRISPR and other newer genome-editing techniques.
A regulator should not assume that a new technique is exempt simply because it does not introduce foreign genetic material.
EUR-Lex+1
Case 2. Confédération paysanne v Premier ministre (2023)
Court of Justice of the European Union · Case C-688/21 · Judgment of 7 February 2023
Background:
The dispute concerned whether organisms produced through particular in-vitro random mutagenesis techniques could benefit from the exemption under EU GMO legislation.
Legal question:
Could a newer or modified technique qualify for an exemption merely because it used processes similar to those of an established technique?
Judgment:
The Court emphasized that the exemption must be interpreted strictly. It is not sufficient to establish that the genetic modification process resembles a conventional technique; the relevant characteristics of the technique and its safety history must also be considered.
Importance for Ukraine:
This judgment is useful when assessing whether newer synthetic biology techniques should receive different regulatory treatment from established genetic modification methods.
EUR-Lex
Case 3. Commission v Poland (Białowieża Forest) (2018)
Court of Justice of the European Union · Case C-441/17 · Judgment of 17 April 2018
Background:
The case concerned forestry operations in the Białowieża Forest and the protection of a site of major ecological importance.
Legal question:
Whether state-authorized activities could proceed without adequately satisfying applicable environmental protection obligations.
Legal principle:
Environmental protection obligations and the requirements of EU nature conservation legislation must be respected when activities may adversely affect protected ecosystems.
Importance for Ukraine:
Although this was not a synthetic biology dispute, its environmental protection principles are relevant when evaluating the release of engineered microorganisms, gene drives or other biological systems that could affect protected ecosystems.
EUR-Lex
10. Liability for Synthetic Biology Violations
Ukraine's GMO legislation establishes administrative and financial consequences for violations.
Article 41 of Law No. 3339-IX provides for financial penalties, including:
| Violation | Penalty for legal entities |
|---|---|
| Violation of biosafety requirements in closed-system genetic engineering | 10–15 minimum monthly wages |
| Violation of GMO handling requirements during open-system research and testing | 15–20 minimum monthly wages |
The law also provides for enforcement proceedings under Article 42.
Depending on the nature of the violation, additional consequences may arise under environmental, food-safety, public-health and criminal legislation.
Potential legal consequences include:
Suspension or restriction of unlawful activities.
Administrative financial penalties.
Withdrawal or restriction of market authorization.
Environmental remediation obligations.
Compensation for proven damage.
Criminal liability where the statutory elements of an offence are satisfied.
ipLex Законодавство України+1
11. Intellectual Property Rights in Synthetic Biology
Synthetic biology raises important intellectual property questions because researchers can create new biological sequences, engineered microorganisms, synthetic enzymes and biological manufacturing processes.
Ukraine's Law on Protection of Rights to Inventions and Utility Models is relevant.
Important legal questions include:
Patentability of synthetic organisms
Whether an engineered organism or biological invention qualifies for patent protection depends on the applicable patentability requirements and statutory exclusions.
Synthetic DNA sequences
Patent applications involving DNA sequences must satisfy the relevant requirements of novelty, inventive step and industrial applicability.
Ownership of synthetic biological inventions
Ownership may depend on employment agreements, research funding agreements, institutional policies and contractual arrangements.
Research and commercial licensing
Universities, biotechnology companies and pharmaceutical manufacturers must consider patent ownership, licensing and technology-transfer obligations.
A patent does not replace biosafety approval or environmental authorization.
12. Government Regulation and Institutional Accountability
Synthetic biology requires coordination among several Ukrainian public authorities.
Their responsibilities may include:
Ministry of Health: public health and sanitary requirements.
Ministry responsible for environmental policy: environmental protection and impact assessment.
Ministry responsible for economic development and agriculture: relevant GMO and agricultural regulatory functions.
State environmental inspection authorities: environmental compliance and enforcement.
State food and consumer protection authorities: food and feed safety controls.
Relevant scientific and research institutions: scientific evaluation and biosafety expertise.
The precise competent authority depends on the type of activity and the current allocation of statutory responsibilities.
13. Emerging Legal Challenges in Ukraine
Several important legal questions remain relevant to the development of synthetic biology.
A. CRISPR regulatory uncertainty
New gene-editing techniques can create organisms without introducing foreign genetic material. Determining their regulatory status is an important challenge.
B. Artificial microorganisms
The creation of microorganisms with synthetic genomes raises questions about containment, environmental release and biological risk.
C. Gene-drive technologies
Gene drives may spread genetic modifications through populations. Their environmental consequences require careful assessment.
D. Synthetic biology and national security
Biological engineering can have dual-use applications. Research governance must address legitimate scientific development alongside biological security risks.
E. Cross-border biotechnology research
International research collaborations raise questions concerning genetic-resource access, material transfers, intellectual property and biosafety approvals.
F. Environmental liability
Accidental release of engineered organisms could create difficult questions about causation, responsibility, remediation and compensation.
G. Regulation of non-GMO biotechnology
The distinction between GMO products and other biotechnology products is especially significant because certain non-GMO biotechnology activities may still require a positive environmental impact assessment under Ukrainian law.
14. Critical Legal Analysis
Ukraine's synthetic biology regulatory framework can be understood through five principal legal principles:
| Principle | Legal significance |
|---|---|
| Precautionary principle | Preventing potentially serious biological and environmental harm |
| Biosafety principle | Ensuring safe research, handling and containment |
| Environmental responsibility | Protecting biodiversity and ecological systems |
| Transparency | Providing access to relevant GMO and environmental information |
| Accountability | Establishing responsibility for regulatory violations |
An important development is the government's September 2025 proposal for a broader biosafety and biosecurity framework. It contemplated specific regulation of biosynthetic activity, biological agents, biological hazards and institutional responsibilities. A government-approved draft should not, however, be confused with an enacted law.
Interfax-Ukraine
15. Conclusion
Synthetic biology in Ukraine is governed through a combination of genetic-engineering legislation, GMO regulation, environmental assessment, public-health safeguards, food and pharmaceutical legislation and international biosafety obligations.
Law No. 3339-IX of 2023 is the central modern statute, while Law No. 1103-V of 2007 provides an important part of the earlier biosafety framework.
Three major legal conclusions emerge:
Genetic engineering requires regulatory oversight: New biological organisms and genetic-engineering activities must be classified under the applicable statutory framework.
Environmental protection extends beyond conventional GMOs: Certain other biotechnology products and activities may also require environmental impact assessment.
Scientific innovation does not eliminate legal accountability: Researchers, laboratories and biotechnology companies remain subject to applicable biosafety, environmental and commercial obligations.
The central challenge for Ukraine is to establish a regulatory system that accommodates scientific innovation while protecting human health, biodiversity, environmental integrity and biological security.
16. Important Legal References for Academic Research
| Legal authority | Relevance |
|---|---|
| Constitution of Ukraine, Articles 3, 16, 27, 28 and 50 | Human rights and environmental protection |
| Law No. 3339-IX (2023) | Modern genetic-engineering and GMO regulation |
| Law No. 1103-V (2007) | State biosafety framework |
| Environmental Impact Assessment Law (2017) | Environmental assessment |
| Public Health System Law | Public health safeguards |
| Cartagena Protocol | International GMO biosafety |
| Nagoya Protocol | Genetic resources and benefit-sharing |
| EU Directive 2001/18/EC | GMO environmental regulation |
| EU Directive 2009/41/EC | Contained use of genetically modified microorganisms |
Primary research sources:
Official Ukrainian GMO and genetic-engineering legislation – Law No. 3339-IX.
Law No. 1103-V – Ukrainian State Biosafety System.
Related Ukrainian implementing regulations and legislation.
CJEU Case C-528/16 – Confédération paysanne.
CJEU Case C-688/21 – Mutagenesis exemption.
CJEU Case C-441/17 – European Commission v Poland.
Academic note: The two Confédération paysanne judgments are particularly useful for research on genome editing, while the Białowieża judgment provides a comparative environmental-protection principle. None should be represented as a Ukrainian Supreme Court ruling.

comments